Clinical Trial

Triosephosphate Isomerase Level in Relation to Rheumatoid Aerthritis Activity and Structural Damage

Name: Triosephosphate Isomerase Level in Relation to Rheumatoid Aerthritis Activity and Structural Damage — clinical trial record (NCT07105566)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

1. Assess the serum level of TPI in patients with RA compared to healthy controls. 2. Correlate serum level of TPI and disease activity. 3. Correlation of serum TPI level with US7 damage index

Trial Details

NCT Number	NCT07105566
Lead Sponsor	Assiut University
Conditions	Rheumatoid Arthritis
Enrollment	70 participants
Start Date	2025-09
Primary Completion	2027-09 (estimated)
Study Completion	2027-10 (estimated)
Updated on ClinicalTrials.gov	2025-08-06